Search research articles
Contact Us
Filters
Showing results (171-180 of 210) with videos related to
Page
of 21
Sort By:
The Lancet. Oncology
|
December 8, 2014
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
Amit M Oza, David Cibula, Ana Oaknin Benzaquen, et al.
Endocrinology
|
September 9, 2006
Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones
Shoshana Yakar, Nomeli P Nunez, Patricia Pennisi, et al.
JCO Precision Oncology
|
May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer
Ansh Kapil, Henrik Failmezger, Yu Fu, et al.
British Journal of Cancer
|
October 25, 2018
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
Darren R Hodgson, Brian A Dougherty, Zhongwu Lai, et al.
JCO Precision Oncology
|
July 12, 2021
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health
P Mickey Williams, Thomas Forbes, Steven P Lund, et al.
Cancer Research
|
September 6, 2005
Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells
Julie A Hong, Yang Kang, Ziedulla Abdullaev, et al.
Clinical Chemistry
|
September 2, 2020
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group
James H Godsey, Angela Silvestro, J Carl Barrett, et al.
Molecular Cancer
|
May 29, 2024
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1
Theresa A Proia, Maneesh Singh, Richard Woessner, et al.
Cancer Cell
|
December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 210) with videos related to
Sort By:
Page
of 21
The Lancet. Oncology
|
December 8, 2014
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
Amit M Oza, David Cibula, Ana Oaknin Benzaquen, et al.
Endocrinology
|
September 9, 2006
Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones
Shoshana Yakar, Nomeli P Nunez, Patricia Pennisi, et al.
JCO Precision Oncology
|
May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer
Ansh Kapil, Henrik Failmezger, Yu Fu, et al.
British Journal of Cancer
|
October 25, 2018
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
Darren R Hodgson, Brian A Dougherty, Zhongwu Lai, et al.
JCO Precision Oncology
|
July 12, 2021
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health
P Mickey Williams, Thomas Forbes, Steven P Lund, et al.
Cancer Research
|
September 6, 2005
Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells
Julie A Hong, Yang Kang, Ziedulla Abdullaev, et al.
Clinical Chemistry
|
September 2, 2020
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group
James H Godsey, Angela Silvestro, J Carl Barrett, et al.
Molecular Cancer
|
May 29, 2024
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1
Theresa A Proia, Maneesh Singh, Richard Woessner, et al.
Cancer Cell
|
December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Page
of 21